Probiotics for Irritable Bowel Syndrome: Guidelines (ACG, AGA, BSG) and Trial Evidence
How the AGA, ACG, BSG and NICE guidelines differ on probiotics for IBS, and which individual strains had positive meta-analyses, with the limits of that evidence.
Content last updated . This page has not been medically reviewed.
Read this first
The NHS (UK) advises seeing a GP if diet changes and pharmacy medicines are not helping IBS symptoms. [1] Bloating together with unintentional weight loss, or with blood in the stool, is a reason to see a clinician. [2] Do not replace prescribed IBS treatment with a probiotic.The short answer
Guidelines disagree. The AGA says to use probiotics for IBS only in clinical trials. The ACG suggests against them for overall IBS symptoms. The BSG gives a weak recommendation that they can be tried. [3] No guideline picks a specific strain. [3]What the guidelines say
| Body (country, year) | Statement on probiotics for IBS | Strength and evidence |
|---|---|---|
| AGA (US, 2020) | Probiotics only in the context of a clinical trial. [3][4] | No recommendation; knowledge gap |
| ACG (US, 2021) | Suggests against probiotics for global IBS symptoms. [3] | Conditional; very low evidence |
| BSG (UK, 2021) | Probiotics can be an effective treatment for general symptoms and abdominal pain, but no species or strain can be recommended; try for up to 12 weeks and stop if no improvement. [3] | Weak; very low evidence |
| NICE (UK, CG61, 2008, last updated 2017) | People who choose to try probiotics should take the product for at least 4 weeks while monitoring the effect. [5] | Not stated in the part we read |
| NHS (UK) | Lists "try probiotics for a month" among self-help steps. [1] It also says there is some evidence they ease some IBS symptoms. [6] | Patient information |
The AGA, ACG and BSG rows come from a 2021 rapid review of guidelines, because we could not open the guideline texts directly. The AGA row was checked against the AGA guideline itself. [4] The 2021 review is older than the newest research below.
What trials and reviews found
The AGA technical review included 55 trials (5,301 patients) testing 44 different strains or combinations, so for most products the evidence comes from a single trial. [7] It concluded no single strain or combination had been studied rigorously enough. [7]A 2026 meta-analysis looked only at single-strain products against placebo in IBS (32 articles, 10 strains). [8]
| Strain (as named in the review) | What the meta-analyses found |
|---|---|
| Bifidobacterium longum 35624 (formerly B. infantis) | Efficacy for key IBS symptoms [8] |
| Lactobacillus rhamnosus GG (now Lacticaseibacillus rhamnosus GG) | Efficacy for key IBS symptoms [8] |
| Lactiplantibacillus plantarum 299v (DSM 9843) | Efficacy for key IBS symptoms [8] |
| Saccharomyces cerevisiae CNCM I-3856 | Efficacy for key IBS symptoms [8] |
| Bacillus coagulans Unique IS2 (MTCC 5260) | Efficacy for key IBS symptoms [8] |
| Bacillus coagulans MTCC 5856 | Improved quality of life [8] |
| Saccharomyces boulardii CNCM I-745 | Conflicting results [8] |
| E. coli Nissle 1917, L. gasseri BNR17, L. casei Shirota | No efficacy shown [8] |
The abstract we read does not give doses, durations or symptom-score sizes, so these cannot be compared with each other or turned into advice. Each result applies only to that strain in that product. Do not assume a "multi-strain" product containing one of them performs the same way. [9]
Frequently asked questions
Do probiotics help IBS?
Possibly for some strains, but the AGA could not recommend any and the ACG suggests against them. [4][3]
Which probiotic strain is best for IBS?
Proper evidence not found for a single best strain. A 2026 review found several single strains with positive meta-analyses and others without. [8]
How long should a trial of a probiotic last?
Guidelines differ: the BSG says up to 12 weeks, NICE says at least 4 weeks. Ask a clinician about your own case. [3][5]
Can probiotics replace IBS medicine or diet?
No guideline in these sources says so. Do not change prescribed treatment without your clinician. [1]
Are IBS probiotics safe?
Adverse events were similar to placebo in an umbrella review, but people who are seriously ill or immunocompromised need advice first. [10][11]
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
How to read the evidence labels
Labels used on this page: promising but limited, mixed, insufficient evidence, Proper evidence not found. Amounts and durations in trials are study amounts, not advice.
Limits and uncertainty
- A 2026 umbrella review of 27 systematic reviews found quality low or critically low, with 66.7% rated critically low. [10]
- Certainty was mostly low or very low; only 1% of outcomes were high certainty. [10]
- Effects on bloating and quality of life were small or inconsistent; adverse events were similar to placebo. [10]
- NCCIH said earlier reviews could not identify which strains help. [11]
- Proper evidence not found, in the sources we read, for comparing probiotics head-to-head with the low-FODMAP diet or other treatments. See The low-FODMAP diet.
Safety
References
- NHS, Diet, lifestyle and medicines for IBS. Read 2026-10-22.
- NHS, Bloating. Read 2026-10-22.
- Marlicz W et al., Probiotics in irritable bowel syndrome: is the quest for the right strain over? Rapid review of existing guidelines and recommendations, Prz Gastroenterol 2021. Read 2026-10-22.
- Su GL et al., AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders, Gastroenterology 2020. Read 2026-10-22.
- NICE, Irritable bowel syndrome in adults: diagnosis and management (CG61). Read 2026-10-22.
- NHS, Probiotics. Read 2026-10-22.
- Preidis GA et al., AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders, Gastroenterology 2020. Read 2026-10-22.
- Maslennikov R et al., Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome, J Clin Med 2026. Read 2026-10-22.
- McFarland LV et al., Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis, Front Med 2018. Read 2026-10-22.
- Ballena-Caicedo J et al., Probiotics in Irritable Bowel Syndrome: An Umbrella Review of 27 Systematic Reviews, J Clin Med 2026. Read 2026-10-22.
- NCCIH, Probiotics: Usefulness and Safety. Read 2026-10-22.